Clinical Trial Update: Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy [NA]

View source ↗

Summary

This completed clinical trial evaluated whether vitreous composition, as determined by ultrasound and OCT, influences ranibizumab therapy for choroidal neovascu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Choroidal Neovascularization

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Vision Research Foundation | Conditions: Choroidal Neovascularization | NA | Status: COMPLETED